IAMA Therapeutics to Present at Sachs Associates 23rd Annual Biotech in Europe Forum
GENOA, Italy, September 13, 2023--IAMA Therapeutics, a pharmaceutical company focused on the discovery, development, and commercialization of novel medicines for children affected by brain disorders, today announced that Andrea P. Malizia, Ph.D., Chief Executive Officer, will present and participate in the "Advances in Approaches to Neurological Disorder" panel at the Sachs Associates 23rd Annual Biotech in Europe Forum, taking place September 20-21, 2023, in Basel, Switzerland.